Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01062893 · ClinicalTrials.gov registry record · Phase 2

Combined Spinal/Epidural (CSE) Saline Duration/Spread

A Phase 2 study, sponsored by Wake Forest University Health Sciences.

Terminated
Registry status
Phase 2
Development phase
82
Enrollment target

NCT01062893 is a Phase 2 study that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 82 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01062893, a Phase 2 study, was terminated before completion, sponsored by Wake Forest University Health Sciences.

TERMINATED
Registry status
Phase 2
Development phase
82 participants
Enrollment target

Study Summary

An attempt is being made to see if by injecting a set volume of sterile saline into the epidural space during the treatment of labor pain with a combined spinal/epidural (CSE) increases the amount of pain relief obtained and makes the labor analgesia lasts longer. Subjects are in the study from the time their CSE is placed until they request additional pain medication from the spinal dose of numbing medicine wearing off.

Interventions

  • OTHER Sterile normal saline 0 mls
  • OTHER 15 mls sterile normal saline

Trial Details

FieldValue
Enrollment Target 82 participants
Start Date 2009-08
Est. Completion 2012-09
Phase Phase 2

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT01062893

The ClinicalTrials.gov registry entry for NCT01062893 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Sterile normal saline 0 mls is the first listed.

NCT01062893 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01062893 about?

NCT01062893 is a clinical study titled "Combined Spinal/Epidural (CSE) Saline Duration/Spread". An attempt is being made to see if by injecting a set volume of sterile saline into the epidural space during the treatment of labor pain with a combined spinal/epidural (CSE) increases the amount of pain relief obtained and makes the labor analgesia lasts longer. Subjects are in the study from the ...

What is the current status of trial NCT01062893?

This trial is currently terminated. It is a Phase 2 study. The enrollment target is 82 participants. The study started on 2009-08. Estimated completion is 2012-09.

What interventions are being tested in trial NCT01062893?

The interventions under investigation include: Sterile normal saline 0 mls (OTHER), 15 mls sterile normal saline (OTHER).

Who is sponsoring clinical trial NCT01062893?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.